Assessing measures of glycemic variability

Patent metadata

Field	Value
Publication number	US-9439586-B2
Application number	US-201313854005-A
Country	US
Kind code	B2
Filing date	Mar 29, 2013
Priority date	Oct 23, 2007
Publication date	Sep 13, 2016
Grant date	Sep 13, 2016

Abstract

Methods, devices and systems for receiving an instruction to determine a glycemic variation level, retrieving a stored metric for determining the glycemic variation level, retrieving one or more parameters associated with the retrieved metric analysis, determining the glycemic variation level based on the retrieved one or more parameters for the retrieved metric analysis, and outputting the determined glycemic variation level when it is determined that the retrieved one or more parameters associated with the retrieved metric analysis meets a predetermined condition are disclosed.

First claim

What is claimed is:

1. A method, comprising:
receiving an instruction to determine a glycemic variation level associated with a glycemic variation metric;
retrieving one or more parameters associated with the glycemic variation metric;
retrieving stored glycemic data based on the one or more retrieved parameters;
determining whether the retrieved glycemic data meets one or more predetermined conditions based on the one or more parameters associated with the glycemic variation metric;
if it is determined that the one or more predetermined conditions are met, then determining the glycemic variation level associated with the glycemic variation metric based on the retrieved one or more parameters and the retrieved glycemic data and outputting the determined glycemic variation level;
if it is determined that the one or more predetermined conditions are not met, then outputting a failure notification; and
controlling administration of therapy using a controller based on the determined glycemic variation level.

2. The method of claim 1 , wherein the one or more parameters associated with the glycemic variation metric include a value for a predetermined time period.

3. The method of claim 1 , wherein the one or more parameters associated with the glycemic variation metric include a value for a minimum number of glucose data over a predetermined time period.

4. The method of claim 1 , wherein the one or more parameters associated with the glycemic variation metric include a value for a minimum number of days with available glucose data within a predetermined time period.

5. The method of claim 1 , wherein the determined glycemic variation level is output as one or more of an audible indication, a visual indication, a vibratory indication, or one or more combinations thereof.

6. The method of claim 1 , wherein the determined glycemic variation level is output as a graphical representation of glycemic variation over time.

7. The method of claim 1 , wherein the notification is output as one or more of an audible indication, a visual indication, a vibratory indication, or one or more combinations thereof.

8. The method of claim 1 , including storing the determined glycemic variation level.

9. The method of claim 1 , wherein the glycemic variation metric includes one or more of a standard deviation analysis, Mean Amplitude of Glycemic Excursions (MAGE) analysis, Glycemic Risk Assessment Diabetes Excursion (GRADE) analysis, Lability index analysis, a number of glycemic variation episode excursions analysis, a duration of each glycemic variation episode excursion analysis, an average maximum excursion value analysis, or a low/high blood glucose index analysis.

10. A system, comprising:
a receiver comprising:
one or more processing units; and
a memory for storing instructions which, when executed by the one or more processing units, causes the one or more processing units to receive instructions:
to determine a glycemic variation level associated with a glycemic variation metric;
to retrieve one or more parameters associated with the glycemic variation metric, to retrieve stored glycemic data based on the one or more retrieved parameters;
to determine whether the retrieved glycemic data meets one or more predetermined conditions based on the one or more parameters associated with the glycemic variation metric;
if it is determined that the one or more predetermined conditions are met, then to determine the glycemic variation level associated with the glycemic variation metric based on the retrieved one or more parameters and the retrieved glycemic data and to output the determined glycemic variation level;
if it is determined that the one or more predetermined conditions are not met, then to output a failure notification; and

a therapy unit comprising:
a controller configured to control administration of therapy based on the determined glycemic variation level.

11. The system of claim 10 , wherein the one or more parameters associated with the glycemic variation metric include a value for a predetermined time period.

12. The system of claim 10 , wherein the one or more parameters associated with the glycemic variation metric include a value for a minimum number of glucose data over a predetermined time period.

13. The system of claim 10 , wherein the one or more parameters associated with the glycemic variation metric include a value for a minimum number of days with available glucose data within a predetermined time period.

14. The system of claim 10 , wherein the determined glycemic variation level is output by an output unit as one or more of an audible indication, a visual indication, a vibratory indication, or one or more combinations thereof.

15. The system of claim 10 , wherein the determined glycemic variation level is output by an output unit as a graphical representation of glycemic variation over time.

16. The system of claim 10 , wherein the notification is output by an output unit as one or more of an audible indication, a visual indication, a vibratory indication, or one or more combinations thereof.

17. The system of claim 10 , wherein the memory for storing instructions which, when executed by the one or more processing units, further causes the one or more processing units to store the determined glycemic variation level.

18. The system claim 10 , wherein the glycemic variation metric includes one or more of a standard deviation analysis, Mean Amplitude of Glycemic Excursions (MAGE) analysis, Glycemic Risk Assessment Diabetes Excursion (GRADE) analysis, Lability index analysis, a number of glycemic variation episode excursions analysis, a duration of each glycemic variation episode excursion analysis, an average maximum excursion value analysis, or a low/high blood glucose index analysis.

19. A method, comprising:
retrieving one or more parameters associated with a glycemic variation metric;
retrieving stored glycemic data based on the one or more retrieved parameters;
determining whether the retrieved glycemic data meets one or more predetermined conditions based on the one or more parameters associated with the glycemic variation metric;
if it is determined that one or more predetermined conditions are met, then determining a glycemic variation level associated with the glycemic variation metric based on the retrieved one or more parameters and the retrieved glycemic data and outputting the determined glycemic variation level;
if it is determined that one or more predetermined conditions are not met, then outputting a failure notification; and
controlling administration of therapy using a controller based on the determined glycemic variation level.

20. The method of claim 19 , wherein the glycemic data is based on signals from an analyte sensor, wherein the analyte comprises a plurality of electrodes including a working electrode, wherein the working electrode comprises an analyte-responsive enzyme and/or a mediator, wherein at least one of the analyte-responsive enzyme or the mediator is chemically bonded to a polymer disposed on the working electrode, and wherein at least one of the analyte-responsive enzyme and/or the mediator is crosslinked with the polymer.

Assignees

• Abbott Diabetes Care Inc

Inventors

• Bugler Jolyon Robert

Classifications

• A61B5/01

  Measuring temperature of body parts {; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue} (clinical contact thermometers G01K13/20) · CPC title

• A61B5/7455

  characterised by tactile indication, e.g. vibration or electrical stimulation · CPC title

• A61B5/0002

  Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network (endoradiosondes A61B5/07) · CPC title

• A61B5/14865

  invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors · CPC title

• A61B5/7405

  using sound · CPC title